Here we have used genetically modified mice with a defect in cholesterol synthesis to determine the consequences of decreased brain cholesterol, in the absence of the hyperglycemia and impaired insulin signaling found in diabetic mice. The gene discussed is INS; the disease is Hyperglycemia.